Mercury Laboratories Ltd.
Snapshot View

849.00 +26.40 ▲3.2%

28 November 2022, 04:01:00 PM
Volume: 626

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.mercurylabs.com
Market Cap 100.87 Cr.
Enterprise Value(EV) 99.94 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 50.68 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 16.59 Trailing Twelve Months Ending 2022-09
Industry PE 35.11 Trailing Twelve Months Ending 2022-09
Book Value / Share 371.06 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.27 Calculated using Price: 840.60
Dividend Yield 0.42 Period Ending 2022-03
No. of Shares Subscribed 0.12 Cr. 1,200,000 Shares
FaceValue 10
Company Profile
The company is engaged in manufacturing of pharmaceutical products. It is mainly dedicated to Mother and child care products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+3.21%
1 Week
-2.26%
1 Month
+51.34%
3 Month
+74.33%
6 Month
+73.27%
1 Year
+37.53%
2 Year
+73.39%
5 Year
+83.31%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 23.18 19.75 19.62 11.67 7.92 10.26 10.59 15.50 9.55
Return on Capital Employed (%) 26.27 21.32 21.58 18.93 9.89 13.77 13.25 20.56 12.53
Return on Assets (%) 8.82 8.01 8.81 5.54 3.92 5.20 5.68 8.77 5.73

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 15 18 22 24 26 29 32 37 40 45
Non Curr. Liab. 5 4 4 10 12 11 9 10 9 6
Curr. Liab. 19 21 20 17 13 17 15 19 14 18
Minority Int.
Equity & Liab. 40 43 47 51 52 57 56 65 63 69
Non Curr. Assets 20 20 19 20 22 25 25 28 27 26
Curr. Assets 21 23 28 31 30 32 32 38 36 43
Misc. Exp. not W/O
Total Assets 40 43 47 51 52 57 56 65 63 69

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 41 41 48 48 52 56 57 69 58 69
Other Income 1 1 1 0 0 1 1 1 1 1
Total Income 42 42 48 48 52 57 58 69 59 70
Total Expenditure -35 -35 -41 -41 -47 -50 -51 -59 -51 -59
PBIDT 7 7 7 7 5 7 7 10 8 11
Interest -1 -1 -1 -1 -1 -1 -1 -1 0 0
Depreciation -1 -1 -1 -1 -1 -2 -2 -2 -2 -2
Taxation -2 -1 -1 -2 0 -1 -1 -3 -1 -2
Exceptional Items 0 0 0
PAT 3 3 4 3 2 3 3 5 4 6
Adjusted EPS 27 28 33 23 17 24 27 44 31 51

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 7 3 3 0 2 5 5 5 8 5
Cash Fr. Inv. -12 -2 -2 0 -2 -4 -5 -1 -5 -2
Cash Fr. Finan. 5 -1 -2 0 0 1 -3 -3 -1 -1
Net Change 1 0 0 0 0 2 -2 1 2 2
Cash & Cash Eqvt 1 1 1 1 1 4 1 3 5 7

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 73.62 73.62 73.66 73.66 73.66 73.66 73.66 73.66 73.66
Public 26.38 26.38 26.34 26.34 26.34 26.34 26.34 26.34 26.34
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 24 Nov 2022
Disclosure Of Related Party Transactions For The Half Yearly Ended Sep 30 2022 Pursuant To Regulation 23(9) Of The SEBI (LODR) Regulations 2015 (''Listing Regulations'')_Mercury Laboratories Limited
Disclosure Of Related Party Transactions For The Half Yearly Ended Sep 30 2022 Pursuant To Regulation 23(9) Of The SEBI (LODR) Regulations 2015 (Listing Regulations)_Mercury Laboratories Limited
Mon, 14 Nov 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Unaudited Standalone Financial Result for the quarter and half year ended on September 30 2022 under Regulation 33 of SEBI (LODR) Regulations 2015 published in newspapers viz. The Free Press (English) and Navshakti (Marathi).
Sat, 12 Nov 2022
Announcement under Regulation 30 (LODR)-Meeting Updates
Disclosure of information under Regulation 30(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 on Creation of new facility for manufacturing Small Volume Parenteral(SVPs) at Jarod

Technical Scans View Details >>

Mon, 28 Nov 2022
High Delivery Percentage High Delivery Percentage
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 6 Months High Increase 6 Months
High Increase 1 Year High Increase 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 248,271.19 1,034.75 +0.1%
Divi's Laboratories Ltd. 89,610.25 3,375.55 +1.0%
Cipla Ltd. 88,883.00 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. 73,293.35 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. 67,892.96 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. 55,408.60 1,637.15 +0.6%
Max Healthcare Institute Ltd. 42,945.22 442.70 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.34 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.96 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-09 34.64 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.57 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.92 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.52 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-09 45.51 442.70 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.66 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.39 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-09 4.06 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.35 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.10 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-09 6.21 442.70 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 442.70 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 442.70 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 442.70 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 442.70 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,034.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,375.55 +1.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,101.30 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,402.00 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,721.85 -1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,637.15 +0.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 442.70 +2.6%

FAQ's On Mercury Laboratories Ltd.

What is Mercury Laboratories share price?

Can I buy Mercury Laboratories shares now?

What is the Dividend Yield of Mercury Laboratories?

What is the Market Cap of Mercury Laboratories?

What are the key metrics to analyse Mercury Laboratories?

What is the 52 Week High and Low of Mercury Laboratories?

What is the trend of Mercury Laboratories share price?